Literature DB >> 19167211

Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes.

Guoliang Qing1, M Celeste Simon.   

Abstract

Intra-tumoral hypoxia (low oxygen [O(2)] level) is an independent indicator of unfavorable patient diagnosis, and increasing evidence demonstrates that hypoxia contributes to a more aggressive tumor phenotype. Adaptation to hypoxia is predominantly regulated by two structurally related hypoxia inducible factors, HIF-1alpha and HIF-2alpha, which activate the expression of genes involved in proliferation, metabolism, angiogenesis, and metastasis. While highly homologous, HIF-1alpha and HIF-2alpha have been shown to have different roles in tumorigenesis dependent on specific tumor microenvironments. Here we summarize recent studies on HIF-2alpha and discuss the potential mechanisms whereby it contributes to tumor aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167211      PMCID: PMC3146034          DOI: 10.1016/j.gde.2008.12.001

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  54 in total

1.  Hypoxia requires notch signaling to maintain the undifferentiated cell state.

Authors:  Maria V Gustafsson; Xiaowei Zheng; Teresa Pereira; Katarina Gradin; Shaobo Jin; Johan Lundkvist; Jorge L Ruas; Lorenz Poellinger; Urban Lendahl; Maria Bondesson
Journal:  Dev Cell       Date:  2005-11       Impact factor: 12.270

Review 2.  Hypoxia-inducible factors, hypoxia, and tumor angiogenesis.

Authors:  Michaela Gruber; M Celeste Simon
Journal:  Curr Opin Hematol       Date:  2006-05       Impact factor: 3.284

3.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.

Authors:  H Tian; S L McKnight; D W Russell
Journal:  Genes Dev       Date:  1997-01-01       Impact factor: 11.361

4.  The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha.

Authors:  E H Gort; G van Haaften; I Verlaan; A J Groot; R H A Plasterk; A Shvarts; K P M Suijkerbuijk; T van Laar; E van der Wall; V Raman; P J van Diest; M Tijsterman; M Vooijs
Journal:  Oncogene       Date:  2007-09-17       Impact factor: 9.867

5.  Hypoxia-driven proliferation of embryonic neural stem/progenitor cells--role of hypoxia-inducible transcription factor-1alpha.

Authors:  Tong Zhao; Cui-ping Zhang; Zhao-hui Liu; Li-ying Wu; Xin Huang; Hai-tong Wu; Lei Xiong; Xuan Wang; Xiao-min Wang; Ling-ling Zhu; Ming Fan
Journal:  FEBS J       Date:  2008-03-13       Impact factor: 5.542

6.  Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

Authors:  Balaji Krishnamachary; David Zagzag; Hideko Nagasawa; Karin Rainey; Hiroaki Okuyama; Jin H Baek; Gregg L Semenza
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

7.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.

Authors:  T G Graeber; C Osmanian; T Jacks; D E Housman; C J Koch; S W Lowe; A J Giaccia
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

8.  Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency.

Authors:  Mayka Sanchez; Bruno Galy; Martina U Muckenthaler; Matthias W Hentze
Journal:  Nat Struct Mol Biol       Date:  2007-04-08       Impact factor: 15.369

9.  Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; H Turley; K Talks; F Pezzella; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

10.  HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.

Authors:  John D Gordan; Jessica A Bertout; Cheng-Jun Hu; J Alan Diehl; M Celeste Simon
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

View more
  53 in total

Review 1.  Systems biology of pro-angiogenic therapies targeting the VEGF system.

Authors:  Feilim Mac Gabhann; Amina A Qutub; Brian H Annex; Aleksander S Popel
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 2.  Effects of hypoxia and HIFs on cancer metabolism.

Authors:  Vera Mucaj; Jessica E S Shay; M Celeste Simon
Journal:  Int J Hematol       Date:  2012-04-27       Impact factor: 2.490

3.  Angiogenesis: escape from hypoxia.

Authors:  Mathew L Coleman; Peter J Ratcliffe
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

Review 4.  Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities.

Authors:  Young-Myeong Kim; Hyun-Ock Pae; Jeong Euy Park; Yong Chul Lee; Je Moon Woo; Nam-Ho Kim; Yoon Kyung Choi; Bok-Soo Lee; So Ri Kim; Hun-Taeg Chung
Journal:  Antioxid Redox Signal       Date:  2010-10-26       Impact factor: 8.401

5.  DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxia.

Authors:  Gabriel Lachance; James Uniacke; Timothy E Audas; Chet E Holterman; Aleksandra Franovic; Josianne Payette; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-09       Impact factor: 11.205

6.  Human cancers converge at the HIF-2alpha oncogenic axis.

Authors:  Aleksandra Franovic; Chet E Holterman; Josianne Payette; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

7.  In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.

Authors:  Rodrigo A Toledo; Yuejuan Qin; Subramanya Srikantan; Nicole Paes Morales; Qun Li; Yilun Deng; Sang-Woo Kim; Maria Adelaide A Pereira; Sergio P A Toledo; Xiaoping Su; Ricardo C T Aguiar; Patricia L M Dahia
Journal:  Endocr Relat Cancer       Date:  2013-05-21       Impact factor: 5.678

8.  Regulating the ARNT/TACC3 axis: multiple approaches to manipulating protein/protein interactions with small molecules.

Authors:  Yirui Guo; Carrie L Partch; Jason Key; Paul B Card; Victor Pashkov; Anjana Patel; Richard K Bruick; Heiko Wurdak; Kevin H Gardner
Journal:  ACS Chem Biol       Date:  2012-12-26       Impact factor: 5.100

9.  Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.

Authors:  Zhao-Li Zhou; Zhi-Guo Luo; Bing Yu; Yi Jiang; Yi Chen; Jian-Ming Feng; Mei Dai; Lin-Jiang Tong; Zheng Li; Yuan-Chao Li; Jian Ding; Ze-Hong Miao
Journal:  Mol Cancer       Date:  2010-10-11       Impact factor: 27.401

Review 10.  HIF-1: upstream and downstream of cancer metabolism.

Authors:  Gregg L Semenza
Journal:  Curr Opin Genet Dev       Date:  2009-11-26       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.